(CNR) Core Natural Resources - Ratings and Ratios
Coal, Export, Mining, Terminal
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.45% |
| Yield on Cost 5y | 6.01% |
| Yield CAGR 5y | -31.72% |
| Payout Consistency | 69.6% |
| Payout Ratio | 31.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 45.7% |
| Value at Risk 5%th | 70.7% |
| Relative Tail Risk | -6.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.09 |
| Alpha | -24.15 |
| CAGR/Max DD | 0.33 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.394 |
| Beta | 0.550 |
| Beta Downside | 0.851 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.14% |
| Mean DD | 20.68% |
| Median DD | 15.62% |
Description: CNR Core Natural Resources November 07, 2025
Core Natural Resources, Inc. (NYSE:CNR) produces, sells, and exports metallurgical and thermal coal from the United States, operating through two primary segments: the Pennsylvania Mining Complex (PAMC) and the CONSOL Marine Terminal.
The PAMC segment mines and markets bituminous coal to power generators, industrial users, and metallurgical customers, while the CONSOL Marine Terminal provides export services via the Port of Baltimore, handling both thermal and metallurgical coal shipments.
Formerly known as CONSOL Energy Inc., the company rebranded to Core Natural Resources in January 2025; it traces its origins to 1864 and is headquartered in Canonsburg, Pennsylvania.
Recent data (2023) show the PAMC segment produced roughly 25 million short tons of coal, with export volumes from the Baltimore terminal hovering around 5 million short tons, and operating cash flow exceeding $300 million. Key economic drivers include global steel production trends (which underpin metallurgical coal demand) and the U.S. energy transition that pressures thermal-coal consumption; regulatory scrutiny and ESG considerations remain material uncertainties for the business.
For a deeper dive into CNR’s valuation metrics and peer comparison, the ValueRay platform offers a concise, data-rich overview.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (-43.4m TTM) > 0 and > 6% of Revenue (6% = 221.5m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -12.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 17.08% (prev 9.21%; Δ 7.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 319.8m > Net Income -43.4m (YES >=105%, WARN >=100%) |
| Net Debt (-26.4m) to EBITDA (443.3m) ratio: -0.06 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.82 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (51.6m) change vs 12m ago 73.74% (target <= -2.0% for YES) |
| Gross Margin 13.72% (prev 52.20%; Δ -38.49pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 81.86% (prev 78.66%; Δ 3.21pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.59 (EBITDA TTM 443.3m / Interest Expense TTM 35.8m) >= 6 (WARN >= 3) |
Altman Z'' 1.41
| (A) 0.10 = (Total Current Assets 1.40b - Total Current Liabilities 769.8m) / Total Assets 6.20b |
| (B) 0.15 = Retained Earnings (Balance) 919.6m / Total Assets 6.20b |
| (C) -0.01 = EBIT TTM -56.9m / Avg Total Assets 4.51b |
| (D) 0.33 = Book Value of Equity 787.3m / Total Liabilities 2.42b |
| Total Rating: 1.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 47.20
| 1. Piotroski 4.0pt |
| 2. FCF Yield 1.67% |
| 3. FCF Margin 2.05% |
| 4. Debt/Equity 0.11 |
| 5. Debt/Ebitda -0.06 |
| 6. ROIC - WACC (= -8.51)% |
| 7. RoE -1.87% |
| 8. Rev. Trend 68.41% |
| 9. EPS Trend -46.46% |
What is the price of CNR shares?
Over the past week, the price has changed by +1.18%, over one month by +15.82%, over three months by +5.46% and over the past year by -15.03%.
Is CNR a buy, sell or hold?
- Strong Buy: 3
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CNR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 112.3 | 25.3% |
| Analysts Target Price | 112.3 | 25.3% |
| ValueRay Target Price | 99.7 | 11.4% |
CNR Fundamental Data Overview December 24, 2025
P/E Forward = 8.6133
P/S = 1.2231
P/B = 1.2002
P/EG = 0.3486
Beta = 0.4
Revenue TTM = 3.69b USD
EBIT TTM = -56.9m USD
EBITDA TTM = 443.3m USD
Long Term Debt = 313.2m USD (from longTermDebt, last quarter)
Short Term Debt = 83.8m USD (from shortTermDebt, last quarter)
Debt = 418.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -26.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.53b USD (4.56b + Debt 418.3m - CCE 444.7m)
Interest Coverage Ratio = -1.59 (Ebit TTM -56.9m / Interest Expense TTM 35.8m)
FCF Yield = 1.67% (FCF TTM 75.6m / Enterprise Value 4.53b)
FCF Margin = 2.05% (FCF TTM 75.6m / Revenue TTM 3.69b)
Net Margin = -1.18% (Net Income TTM -43.4m / Revenue TTM 3.69b)
Gross Margin = 13.72% ((Revenue TTM 3.69b - Cost of Revenue TTM 3.19b) / Revenue TTM)
Gross Margin QoQ = 2.40% (prev 1.86%)
Tobins Q-Ratio = 0.73 (Enterprise Value 4.53b / Total Assets 6.20b)
Interest Expense / Debt = 2.54% (Interest Expense 10.6m / Debt 418.3m)
Taxrate = 247.7% (out of range, set to none) (-53.0m / -21.4m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.82 (Total Current Assets 1.40b / Total Current Liabilities 769.8m)
Debt / Equity = 0.11 (Debt 418.3m / totalStockholderEquity, last quarter 3.78b)
Debt / EBITDA = -0.06 (Net Debt -26.4m / EBITDA 443.3m)
Debt / FCF = -0.35 (Net Debt -26.4m / FCF TTM 75.6m)
Total Stockholder Equity = 2.32b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.70% (Net Income -43.4m / Total Assets 6.20b)
RoE = -1.87% (Net Income TTM -43.4m / Total Stockholder Equity 2.32b)
RoCE = -2.16% (EBIT -56.9m / Capital Employed (Equity 2.32b + L.T.Debt 313.2m))
RoIC = -1.14% (negative operating profit) (EBIT -56.9m / (Assets 6.20b - Curr.Liab 769.8m - Cash 444.7m))
WACC = 7.36% (E(4.56b)/V(4.97b) * Re(8.04%) + (debt cost/tax rate unavailable))
Discount Rate = 8.04% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 28.81%
[DCF Debug] Terminal Value 74.46% ; FCFE base≈200.2m ; Y1≈159.2m ; Y5≈106.8m
Fair Price DCF = 38.77 (DCF Value 1.99b / Shares Outstanding 51.2m; 5y FCF grow -24.49% → 3.0% )
EPS Correlation: -46.46 | EPS CAGR: -4.68% | SUE: 0.54 | # QB: 0
Revenue Correlation: 68.41 | Revenue CAGR: 33.95% | SUE: -0.02 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.55 | Chg30d=-0.410 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=7.90 | Chg30d=-0.522 | Revisions Net=+0 | Growth EPS=+633.3% | Growth Revenue=+8.0%
Additional Sources for CNR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle